Anavex Life Sciences (NASDAQ:AVXL – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment […]
Anavex Life Sciences (NASDAQ:AVXL – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm currently has a $13.00 target price on the biotechnology company’s stock. Zacks Investment Research‘s price objective would suggest a potential upside of 15.45% from […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) has received a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokers […]
Cetera Advisor Networks LLC purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 31,074 shares of the biotechnology company’s stock, valued at approximately $558,000. Other large […]
Squarepoint Ops LLC grew its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) by 49.9% during the third quarter, HoldingsChannel.com reports. The firm owned 60,868 shares of the biotechnology company’s stock after purchasing an additional 20,249 shares during the period. Squarepoint Ops LLC’s holdings in Anavex Life Sciences were worth $1,093,000 as of […]